日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung Cancer

在ALK阳性非小细胞肺癌患者中，以较低剂量开始使用阿来替尼的临床意义

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.1209
Kim, Junkyu; Kim, Min-Ji; Kim, Jinyong; Park, Sehhoon; Jung, Hyun Ae; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju; Sun, Jong-Mu
肺癌
肿瘤
肿瘤免疫
ALK
细胞生物学
发表日期：2026
文献求助 收藏

Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor

利用人工智能技术对获得性EGFR酪氨酸激酶抑制剂耐药的非小细胞肺癌患者的肿瘤微环境进行空间分析

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2025-012374.
Yeong Hak Bang # ,Geun-Ho Park # ,Jin Woo Oh # ,Soohyun Hwang ,Jun-Gi Jeong ,Boram Lee ,Cheol Yong Joe ,Hyemin Kim ,Jinyong Kim ,Sehhoon Park ,Hyun Ae Jung ,Jong-Mu Sun ,Jin Seok Ahn ,Myung-Ju Ahn ,Yoon-La Choi ,Chang Ho Ahn ,Siraj M Ali ,Chan-Young Ock ,Se-Hoon Lee
肿瘤
肺癌
EGF
EGFR
发表日期：2025
文献求助 收藏

Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial

帕博利珠单抗辅助治疗完全切除的 I 期肺腺癌（微乳头状或实性组织学亚型）：一项单中心、单臂 II 期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103282
Kim, Jhingook; Bang, Yeong Hak; Park, Sehhoon; Jung, Hyun-Ae; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Jeon, Yeong Jeong; Lee, Junghee; Cho, Jong Ho; Kim, Hong Kwan; Choi, Yong Soo; Zo, Jae Ill; Shim, Young Mog; Kang, Jung Hee; Lee, Jinseon; Choi, Yoon-La; Han, Joungho; Hwang, Soohyun; Lee, Ho Yun; Lee, Se-Hoon
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non-Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study)

用于早期非小细胞肺癌复发实时预测的深度学习模型：一种多模态方法（RADAR CARE 研究）

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-25-00172
Jung, Hyun Ae; Lee, Daehwan; Park, Boram; Lee, Kiwon; Lee, Ho Yun; Kim, Tae Jung; Jeon, Yeong Jeong; Lee, Junghee; Park, Seong Yong; Cho, Jong Ho; Choi, Yong Soo; Park, Sehhoon; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju; Kim, Hong Kwan
肺癌
肿瘤
ADA
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer

达克替尼作为EGFR突变型非小细胞肺癌患者一线治疗的真实世界数据

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-81704-4
Shin, Ji Eun; Jung, Hyun Ae; Park, Sehhoon; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju; Shim, Byoung Yong
EGFR
肺癌
EGF
肿瘤
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Combination of chemotherapy and immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 mutations: a retrospective observational study

化疗联合免疫检查点抑制剂治疗除EGFR、ALK和ROS1突变以外的其他可靶向基因改变的非小细胞肺癌：一项回顾性观察研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14834-1
Shin, Ji Eun; Park, Sehhoon; Jung, Hyun Ae; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju
肺癌
肿瘤
肿瘤免疫
ALK
EGF
EGFR
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Adjuvant Sequential Chemotherapy for Salivary Duct Carcinomas: A Retrospective Comparative Analysis

唾液腺导管癌辅助序贯化疗：一项回顾性比较分析

期刊:Oncology
影响因子:1.8
doi:10.1159/000543281
Jeong, Han-Sin; Kim, Younghac; Choi, Nayeon; Kim, Eun-Hye; Chung, Man Ki; Son, Young-Ik; Oh, Dongryul; Ahn, Yong Chan; Lee, Se-Hoon; Jung, Hyun Ae; Park, Sehhoon; Kim, Jinyong; Jeong, Han-Sin; Ahn, Myung-Ju
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM)

80 mg 奥希替尼治疗伴有表皮生长因子受体突变阳性非小细胞肺癌的软脑膜转移患者的 II 期疗效和安全性研究 (BLOSSOM)

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00708
Park, Sehhoon; Baldry, Richard; Jung, Hyun Ae; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Kim, Yu Jung; Lee, Youngjoo; Kim, Dong-Wan; Kim, Sang-We; Lee, Ki Hyeong; Lee, Won Jae; Choi, Jung Won; Chong, Kyuha; Lee, Jung-Il; Gwon, So-Hyeon; Son, Nak-Hoon; Ahn, Myung-Ju
肺癌
肿瘤
肿瘤免疫
信号转导
神经科学
细胞生物学
发表日期：2024
文献求助 收藏

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

针对 EGFR 或 ALK 突变型非小细胞肺癌患者的阿特珠单抗联合贝伐珠单抗和化疗的 III 期随机研究 (ATTLAS, KCSG-LU19-04)

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.01891
Park, Sehhoon; Kim, Tae Min; Han, Ji-Youn; Lee, Gyeong-Won; Shim, Byoung Yong; Lee, Yun-Gyoo; Kim, Sang-We; Kim, Il Hwan; Lee, Suee; Kim, Yu Jung; Park, Ji Hyun; Park, Sang-Gon; Lee, Ki Hyeong; Kang, Eun Joo; Kim, Ju Won; Shin, Seong-Hoon; Ock, Chan-Young; Nam, Byung-Ho; Lee, Jaebong; Jung, Hyun-Ae; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju
肺癌
肿瘤
肿瘤免疫
ALK
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types

炎症性免疫表型可预测多种癌症类型中免疫检查点抑制剂疗法的良好临床疗效

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-008339
Shen, Jeanne; Choi, Yoon-La; Lee, Taebum; Kim, Hyojin; Chae, Young Kwang; Dulken, Ben W; Bogdan, Stephanie; Huang, Maggie; Fisher, George A; Park, Sehhoon; Lee, Se-Hoon; Hwang, Jun-Eul; Chung, Jin-Haeng; Kim, Leeseul; Song, Heon; Pereira, Sergio; Shin, Seunghwan; Lim, Yoojoo; Ahn, Chang Ho; Kim, Seulki; Oum, Chiyoon; Kim, Sukjun; Park, Gahee; Song, Sanghoon; Jung, Wonkyung; Kim, Seokhwi; Bang, Yung-Jue; Mok, Tony S K; Ali, Siraj M; Ock, Chan-Young
肿瘤
炎症
肿瘤免疫
炎症/感染
免疫/内分泌
发表日期：2024
文献求助 收藏